Advocate
Latest publications
-
WE NEED A COMPREHENSIVE HEPATITIS C PACKAGE OF SERVICES FOR PEOPLE WHO USE AND INJECT DRUGS! “It’s been more than 5 years since we cured hepatitis C...where’s my package?”
Achieving hepatitis C virus (HCV) elimination by 2030 depends on how countries fund prevention, testing, treatment, and care and how they include HCV in efforts for universal health coverage. Investing in elimination requires national programs to provide services for key populations, (...) More
-
Have a heart, save my liver! Where are my diagnostics?
Of the 71 million people living with chronic hepatitis C, only ≈20% are aware of their status and less than 5% of people living in LMICs have been diagnosed.
We need simpler & cheaper tests to scale up diagnosis! More
-
Global Declaration to Eliminate Hepatitis C in People Who Use Drugs: A call for political leaders to take action
Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More
-
WORLD HEPATITIS SUMMIT: NO ELIMINATION WITHOUT DECRIMINALIZATION! 18 civil society organisations call world leaders to promote harm reduction and decriminalise drug use
São Paulo, Brazil – November 2nd 2017.
At the occasion of the World Hepatitis Summit, a large coalition of patients, clinicians, social workers, representatives of the drug using community, researchers, and public health experts express their whole-hearted support to the commitment of the World (...) More -
Equitable access to HCV drugs
Petition to stop Gilead’s anti-diversion program that violates physician and patient rights to protect its profit. More
-
Strengthening Advocacy for Hepatitis C Diagnostics: Georgia Workshop Summary Report
13-15 May 2019, Tbilisi, Georgia
The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More -
Strengthening Advocacy for Hepatitis C Diagnostics: Malaysia Workshop Summary Report
1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More -
Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics Report of the World Community Advisory Board on HCV Generics and Diagnostics 18-20 July 2017, Bangkok, Thailand
In July 2017, 37 treatment activists from 17 countries—including 14 low- and middle-income countries (LMICs)—met with representatives from three generics and three diagnostics companies. This Hepatitis C World Community Advisory Board meeting was an opportunity for activists to present demands (...) More